MW

Maximilian Winter

General Partner at Harmonix

United States

Overview

Work Experience

  • Founder & General Partner

    2017 - Current

    Harmonix is a pioneering venture capital firm investing in data-driven platform companies at the nexus of healthcare, life sciences, and critical infrastructure (deep tech). As key drivers of the fourth Industrial Revolution, engineering biology and computational methodologies are paving the way for a new epoch of commercialized scientific progress that enhances human and planetary well-being. The firm is on its third fund, comprising over 40 trailblazing companies that span AI-powered biotechnology, synthetic biology, healthcare, and critical infrastructure with national security implications. Notable breakthroughs include the first AI-designed drug to undergo clinical trials, a groundbreaking fully automated robotic cloud laboratory for synthetic biology research, and the inaugural rideshare satellite launch into orbit. Esteemed publications such as Bloomberg, BBC, Forbes, and Fortune have spotlighted the fund's portfolio companies for their transformative scientific achievements.

  • Member Board of Directors

    2015

  • Board Observer

    2021

Relevant Websites